ZBH ZBH ジンマ―・バイオメット・ホ―ルディングス



symbol ZBH
会社名 Zimmer Biomet Holdings Inc (ZBH ジンマ―・バイオメット・ホ―ルディングス)
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ジマー・バイオメット・ホールディングス(Zimmer Biomet Holdings Inc.)は整形外科再建製品、スポーツ医学・生物製剤・四肢・外傷用製品、脊椎・骨治癒・頭蓋顎顔面・胸部用製品、歯科インプラント及び関連手術用製品の設計・製造・販売を行う。同社の製品とソリューションは骨・関節・支持軟組織疾患または損傷の患者の治療に使用される。同社は米国及び北・中・南米市場を含む米州、ヨーロッパ、中東及びアフリカ市場を含むEMEA及び日本と他のアジア・太平洋市場を含むアジア太平洋という3つの地域的セグメントを通じて事業を展開する。同社は米州脊椎、骨治癒、頭蓋顎顔面、歯科等の製品種類を有する。  ジンマ―・バイオメット・ホ―ルディングスは米国の医療器具持株会社。主に再建・整形外科用インプラント製品や外科製品を提供する。独自の「小柱網用金属」技術を組み込んだ人口関節製品、脊髄インプラント、関節・歯科用のインプラント、整形外科用の各種手術器具、機器を扱う。本社はインディアナ州。  Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
本社所在地 574 267-6131
代表者氏名 Bryan C. Hanson
代表者役職名 President Chief Executive Officer Director
電話番号 +1 574-267-6131
設立年月日 36892
市場名 NYSE(ニューヨーク証券取引所)
従業員数 19000人
url www.zimmer.com
EBITDA EBITDA(百万ドル) 2563.40000
時価総額 時価総額(百万ドル) 26124.81000
売上高 売上高(百万ドル) 7932.90000
企業価値(EV) 企業価値(EV)(百万ドル) 34520.71000
当期純利益 当期純利益(百万ドル) -370.90000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Zimmer Biomet Holdings Inc revenues increased 2% to $7.93B. Net loss before extraordinary items totaled $370.9M vs. income of $541.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Goodwill impairment increase from $304.7M to $975.9M (expense) Selling general and administrative increase of 9% to $3.38B (expense).



   Combined Physical Therapy Device Market 2021: Strategic Assessment, Latest Innovations, Drivers, Restraints, Challenges to 2027 | BTL Corporate, Zimmer MedizinSysteme GmbH  2021/07/02 09:07:53 OpenPR
An extensive study offering forecast assessment on Combined Physical Therapy Device Market has been broadcasted. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. The report includes a thorough analysis of the global
   Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints  2021/07/01 00:00:00 PR Newswire Asia (English)
SINGAPORE , July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. OSSIS, a New Zealand based company, specializes in complex hip replacements including second-time hip replacement, and replacement involving bone tumours and trauma. "This partnership will allow Zimmer Biomet to provide our extensive network of orthopaedic surgeons with the option of patient-specific implants which are crafted with a combination of clinical and engineering expertise," said Sang Yi , Zimmer Biomet Asia Pacific Group President. "This will further strengthen Zimmer Biomet''s extensive portfolio of revision hip solutions and complementary technologies, with the ultimate goal of providing innovative solutions for complex cases and improving the quality of life of patients." "The partnership with Zimmer Biomet will enhance OSSIS'' ability to support surgeons and patients alike and create a network across the Asia Pacific region of cutting-edge technology and expert capability, " said OSSIS Managing Director , Kelvin Hyland . "This is an exciting step for OSSIS.
   Pneumatic Compression Therapy Market Report- Trends, Growth Demand, Opportunities & Forecast | ArjoHuntleigh , Zimmer Biomet Holdings Inc  2021/06/30 12:55:50 Jumbo News
Pneumatic Compression Therapy Market research report helps in gathering and analysing useful insights such as global market size, forecast and Compound Annual Growth Rate (CAGR) of a particular industry. It also helps in determining the market status, future prospects, growth opportunity, main challenges about the market for any industry. Pneumatic Compression Therapy Market research report []
   2021 Medical Tourism Market Report- Global Industry Analysis | Vitrolife, Zimmer Biomet Holdings Inc  2021/06/30 08:46:00 Jumbo News
ReportsnReports added Medical Tourism Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Medical Tourism Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain []
   Dental Laboratories Market 2020: Research In-Depth Analysis, Market Applications, Key End-Users Forecasts To 2027 by Company Profiles: Dentsply Sirona, Zimmer Biomet, BEGO GmbH, Ultradent Products, GC Corporation, Ivoclar Vivadent  2021/06/30 06:00:47 OpenPR
Dental laboratories market is anticipated to reach US$ 54,008.10 Mn in 2027 from US$ 33,264.24 Mn in 2018. The market is expected to grow with a CAGR of 5.7% from 2019-2027. A Latest intelligence report published by The Insight Partners with
   Is Zimmer Biomet Holdings Inc (ZBH) Going to Burn These Hedge Funds?  2021/06/21 16:17:54 Yahoo Finance
Is Zimmer Biomet Holdings Inc (NYSE:ZBH) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise []
   Global Plastic Surgery Instruments Market COVID 19 Impacted In-Depth Analysis including key players Zimmer Biomet, Sklar Surgical Instruments, B. Braun Melsunge  2021/06/16 19:00:00 iCrowdNewswire
Global Plastic Surgery Instruments Market Plastic surgery is defined as a surgical procedure, which is used performed by trained doctors for restoration, reconstruction or alteration of human body or body []
   Jason Cordell  2021/06/14 14:57:57 Business Alabama
As BioHorizons director of biomaterials, Jason Cordell will manage the companys entire biomaterials product line. He joins BioHorizons from Wright Medical, where he initially managed the biologics portfolio and most recently led the companys sales development efforts. He has also worked at RTI Biologics, a biomaterial supplier for Zimmer Biomet. BioHorizons Birmingham, Alabama biohorizons.com Thank [] The post Jason Cordell appeared first on Business Alabama Magazine .
   Global Robot Grippers Market 2021 Competitive and Regional Analysis by 2026 | Key Players as Schunk, Festo, SMC, Robotiq, Zimmer, Destaco, EMI, IAI  2021/06/11 11:22:40 Jumbo News
As per the research conducted by MarketsandResearch.biz, the report titled Global Robot Grippers Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 includes a lot of details that allow everyone to understand different things without difficulties. In the introductory part of the chapter, details about global Robot Grippers market figures, both historical and []
   Artificial Intelligence in BFSI Market with a Comprehend Key Patterns & Development in Impact of Covid-19 with CAGR of +10% by 2027:Zimmer Biomet Holdings, AlphaSense,  2021/06/11 09:06:15 Jumbo News
The report titled, Artificial Intelligence in BFSI Market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market. The report includes []
   Zimmer Biomet Stock Dips Despite Q1 Earnings Beat, Better-Than-Expected Guidance  2021/05/04 18:41:44 Benzinga
Zimmer Biomet Holdings Inc (NYSE: ZBH ) shares took a hit today despite first-quarter results beating the consensus. Adjusted diluted EPS of $1.71, grew 0.6% Y/Y, and surpassed Wall Street’s estimate of $1.53. It posted Q1 sales of 1,847.4, up 3.6% on a reported basis and 0.8% on a constant currency basis. Revenues came in above the consensus of $1.76 billion. Zimmer saw a rebound in hip procedures, while knee products continued to struggle. Hip sales grew by 3.3% compared to last year, while knees declined … Full story available on Benzinga.com
It's been an eventful year for NeuroOne Medical Technologies Corp (OTCQB: NMTC ), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Minnesota- based company has announced the successful completion of its first performance milestone for its Zimmer Biomet Agreement and closed a $12.5 million private placement. NeuroOne, a cutting-edge electrode company, intends to use its product for medical conditions such as epilepsy, Parkinson's disease, back pain due to failed back surgery, and in the future for incontinence and hypertension. The devices are placed either through smaller incisions or percutaneously. The technology uses photolithography to ensure a consistent product using cost-efficient manufacturing methods. The company has successfully met the first performance milestone in a distribution and development agreement that was signed with Zimmer Biomet last summer. … Full story available on Benzinga.
   The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split  2021/04/15 11:49:24 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ: TXG ) Affimed N.V. (NASDAQ: AFMD ) Bio-Techne Corporation (NASDAQ: TECH ) - announced out-licensing of antibody treatment candidate to Xencor, Inc. (NASDAQ: XNCR ) BioNTech SE (NASDAQ: BNTX ) - reacted to increased EU orders for its COVID-19 vaccine in the wake of the Johnson & Johnson (NYSE: JNJ ) setback Globus Medical, Inc. (NYSE: GMED ) Medpace Holdings, Inc. (NASDAQ: MEDP ) Medtronic plc (NYSE: MDT ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Natus Medical Incorporated (NASDAQ: NTUS ) NuVasive, Inc. (NASDAQ: NUVA ) PLx Pharma Inc. (NASDAQ: PLXP ) PPD, Inc. (NASDAQ: PPD ) - moved on rumors of a potential buyout by Thermo Fisher Scientific Inc. (NYSE: TMO ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 14) Bellerophon Therapeutics, Inc. (NASDAQ: BLPH ) Celyad Oncology SA (NASDAQ: CYAD ) Design Therapeutics, Inc. (NASDAQ: DSGN ) Kronos Bio, Inc. (NASDAQ: KRON ) Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT ) Metacrine, Inc. (NASDAQ: MTCR ) Millendo Therapeutics, Inc. (NASDAQ: MLND ) Nabriva Therapeutics plc (NASDAQ: NBRV ) Osmotica Pharmaceuticals plc (NASDAQ: OSMT ) Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Regenxbio Doses First Patient In Gene Therapy Study REGENXBIO Inc. (Nasdaq: RGNX ) said it dosed the first patient in Cohort 3 of the ongoing Phase I/2 trial of RGX-121 for the treatment of Mucopolysaccharidosis Type II, also known as Hunter Syndrome, in patients up to five years old.
   Bone Implant Market Undertake Strapping Growth By 2027 With B. Braun Melsungen AG, Biotronic, Conmed Corporation, Globus Medical, Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, DePuySynthes, Wright Medical Group N.V, Smith & Nephew plc  2021/03/22 09:02:01 OpenPR
Bone Implant research report provides deep insights into the Global Bone Implant market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the
   Europe Viscosupplementation Market - Emerging Growth By Top Players Sanofi S.A., Anika Therapeutics, Inc., Seikagaku, Zimmer Biomet Holdings Inc., Meda AB (Mylan), Fidia Farmaceutici S.p.A., Bioventus LLC, Ferring B.V  2021/03/19 12:51:43 OpenPR
Patients suffering from OA have a lower-than-normal concentration of HA in their joints. Injecting HA lubricates bones to move smoothly over each other. Viscosupplementation facilitates movement and reduces pain in the arthritic joint. It is often recommended when other nonsurgical

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ZBH ジンマ―・バイオメット・ホ―ルディングス ZBH )


 twitter  (公式ツイッターやCEOツイッターなど)